2021 Autumn Conference – Includes Joint Day with ECNP
Applications of Lessons Learned from 2020
30 September – 02 October, 2021 // Virtual Conference
Distinguished Poster Award Recipient:
|
|||
| Placebo Response Propensity Scale (PRPS) scores and probability of placebo response by disease severity (Morlock) | |||
|
View all Poster PDFs and Abstracts |
|||
30 September 2021 |
|||
| Welcome from the President | Ramy Mahmoud slides video |
||
| Session 1: Applications of Lessons Learned from 2020: Diversity in CNS clinical trials | Chairs: Carla Canuso Jerry Sanacora H. Lynn Starr |
||
| Introduction | Carla Canuso video slides |
||
| Why is diversity in clinical trials important? | David Henderson slides video |
||
| How are we doing? One company’s assessment of diversity in clinical trials | H. Lynn Starr slides video |
||
| Putting new learnings and best practices into action | Lionel Phillips slides video |
||
| The Yale model and our partnered approach: Increasing clinical trial representation through community collaboration and innovation | Tesheia Harris slides video |
||
| Cultural adaptation frameworks and use of real world evidence in the study of diverse populations | Shanaya Rathod slides video |
||
| Recruitment and enrollment panel discussion | Moderators: Carla Canuso Jerry Sanacora video |
||
| FDA OMHHE: Working to advance racial and ethnic minority participation in clinical trials | Richardae Araojo slides video |
||
| Statistical approaches under heterogeneous treatment effects | Mark Rothmann slides video |
||
| EMA Regulatory comment | Florence Butlen-Ducuing slides video |
||
| Discussion | Regulatory speakers video |
||
| Session Summary | Jerry Sanacora Carla Canuso video |
||
|
Poster Session |
Poster PDFs and Abstracts | ||
1 October 2021 |
|||
| Welcome from the Presidents | Gitte Knudsen Ramy Mahmoud slides video |
||
| Session 2: Knowledge of COVID-19 biology / syndromes: How does it lead to new research considerations | Chairs: David Baldwin Kemi Olugemo |
||
| Introduction | Kemi Olugemo slides video |
||
| COVID-19 and mental health: A global perspective | Christoph Correll* slides video |
||
| Nature and course of psychological symptoms in the general population during the pandemic: Insights from national cross-sectional and longitudinal studies | Samuel Chamberlain* |
||
| 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: A retrospective cohort study using electronic health records | Maxime Taquet slides video |
||
| Early effects of the pandemic on individuals with serious mental illness: Findings from multisite Ecological Momentary Assessment (EMA) studies | Raeanne Moore slides video |
||
| Panel discussion: Includes patient advocacy perspective | Discussant: Erik Van der Eycken video |
||
| Challenges for trial design and analysis during the pandemic era: Development of the CONSERVE statement | Richard Emsley slides video |
||
| Discussion – DeMartinis and Emsley | video
|
||
| Session Summary | Kemi Olugemo video |
||
| Session 3: Lessons learned for the good – Overcoming obstacles | Chairs: Dragana Bugarski-Kirola Gerard Dawson |
||
| Introduction | Gerard Dawson slides video |
||
| COVID-19 lockdown conditions and depression assessment data from an exploratory MDD clinical trial | Nicholas DeMartinis slides video |
||
| Panel: Impact of COVID-19 pandemic on participants, operational aspects of clinical conduct and implication for data analysis | |||
| Introduction | Dragana Bugarski-Kirola video |
||
| Impact of COVID-19 pandemic on Seriously Mentally Ill (SMI) subjects in clinical trials | Robert Litman slides video |
||
| Case study of an Alzheimer’s disease (AD) international trial successfully initiated during the first wave of the COVID pandemic | Joanne Bell slides video |
||
| Clinical trial continuity in the wake of a pandemic | Ramzey Odetalla slides video |
||
| Conducting a pediatric orphan (Tourette’s study pre & during COVID shutdown: Experience and lessons learned | Atul Mahableshwarkar slides video |
||
| Panel Discussion | Facilitator: Gerard Dawson video |
||
| Impact of COVID-19 lockdown on data integrity and analysis of a transdiagnostic study with two patient populations | Dennis Hernaus slides video |
||
| Panel: Regulatory discussants | Discussants: intro video Valentina Mantua slides videoLorenzo Guizzaro slides video |
||
| Panel Discussion | All speakers video |
||
| Session Summary | Gerard Dawson video |
||
2 October 2021 |
|||
|
Saturday Concurrent Working Group Sessions |
|||
| Innovative technologies for CNS clinical trials | Chairs: Richard Keefe Michael Davis |
||
| Joint ISCTM/ECNP COVID-19 methodologies blueprint | Chairs: Dragana Bugarski-Kirola Gerard Dawson Kemi Olugemo |
||
| Orphan diseases | Chairs: Joan Busner Gahan Pandina |
||
| *Full presentation not released | |||